Valeo Pharma (TSX:VPH) Total Payout Ratio : 0.00 (As of Dec. 15, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Valeo Pharma Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Valeo Pharma's current Total Payout Ratio is 0.00.

Valeo Pharma Total Payout Ratio Historical Data

The historical data trend for Valeo Pharma's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valeo Pharma Total Payout Ratio Chart

Valeo Pharma Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Total Payout Ratio

Get a 7-Day Free Trial

0.86

1.45

0.81

0.14

Valeo Pharma Quarterly Data
	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
Total Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Valeo Pharma's Total Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Valeo Pharma's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Valeo Pharma's Total Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Valeo Pharma's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Valeo Pharma's Total Payout Ratio falls into.

Valeo Pharma Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Valeo Pharma's Total Payout Ratio for the fiscal year that ended in Oct. 2023 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	3.92	+	0)	/	-27.808
	=	0.14

Valeo Pharma's Total Payout Ratio for the quarter that ended in Jul. 2024 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	0)	/	-8.192
	=	0.00

Valeo Pharma Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Valeo Pharma's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Valeo Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valeo Pharma Inc (TSX:VPH) » Definitions » Total Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9

Website

https://www.valeopharma.com

Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.

Executives

Luc Mainville	Senior Officer
100079 Canada Inc.	10% Security Holder
Richard J. Mackay	Director, Director or Senior Officer of 10% Security Holder
Steve Saviuk	Director, Director or Senior Officer of 10% Security Holder, Senior Officer
Jeffrey Michael Skinner	Senior Officer
Frederic Fasano	Director
Guy Paul Allard	Director or Senior Officer of 10% Security Holder, Senior Officer
Marc François Léger	Senior Officer

Valeo Pharma Headlines

No Headlines